Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCB123667 phase 1 study in advanced solid tumors
NL-OMON60905Phase 1Completed
- Sponsor
- Incyte
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of INCB123667 in Nonhematologic neoplasms (2 arms), sponsored by Incyte. Started Aug 2022; status: completed.
02
Drugs
INCB123667
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on NL-OMON60905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60905.